Product DevelopmentFutura's female sexual dysfunction product, WSD4000, has delivered positive results in a home user study, which saw the product deliver an overall positive change in sexual function after four weeks.

Product LaunchThe year saw the business achieve several key milestones including the launch of Eroxon in the US (via partner Haleon) alongside over 15 countries across the Americas, Middle East and Europe.

Bears Say

Market OutlookInvestors will rightly be focused on 2025 and outlook following the trading update on Jan 30 flagging slower-than-expected initial consumer uptake in the US and slower-than-planned EU market roll-outs.

Revenue ForecastFutura has reiterated that it expects FY25 revenues to be approx. 50% lower than previously expected.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

0.65% Insiders

―

Mutual Funds

<0.01% Other Institutional Investors

99.35% Public Companies and

Individual Investors

Detailed Ownership Overview >

FUM FAQ

What was Futura Medical PLC’s price range in the past 12 months?

Futura Medical PLC lowest share price was 7.00p and its highest was 45.56p in the past 12 months.

What is Futura Medical PLC’s market cap?

Futura Medical PLC’s market cap is £40.77M.

When is Futura Medical PLC’s upcoming earnings report date?

Futura Medical PLC’s upcoming earnings report date is Sep 23, 2025 which is in 57 days.

How were Futura Medical PLC’s earnings last quarter?

Futura Medical PLC released its earnings results on Apr 15, 2025. The company reported 0.001p earnings per share for the quarter, beating the consensus estimate of N/A by 0.001p.

Is Futura Medical PLC overvalued?

According to Wall Street analysts Futura Medical PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Futura Medical PLC pay dividends?

Futura Medical PLC does not currently pay dividends.

What is Futura Medical PLC’s EPS estimate?

Futura Medical PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Futura Medical PLC have?

Futura Medical PLC has 303,703,580 shares outstanding.

What happened to Futura Medical PLC’s price movement after its last earnings report?

Futura Medical PLC reported an EPS of 0.001p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 7.709%.

Which hedge fund is a major shareholder of Futura Medical PLC?

Currently, no hedge funds are holding shares in GB:FUM

Futura Medical Stock Smart Score

Underperform

Fundamentals

Return on Equity

17.91%

Trailing 12-Months

Asset Growth

15.01%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Futura Medical PLC

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.